Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Yang

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
The Annals of Thoracic Surgery|July 24, 2019
American Board of Thoracic Surgery 10-Year Maintenance of Certification Exam Improves and Validates Knowledge AcquisitionYolonda L Colson, Joe B Putnam, Stephen C Yang, et al.
Investigational New Drugs|February 28, 2006
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinomaElisabeth I Heath, Barbara A Burtness, Lawrence Kleinberg, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 2019
Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancerMatthew J Bott, Stephen C Yang, Bernard J Park, et al.
Arthritis and Rheumatism|November 30, 2006
Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertensionLionel Schachna, Thomas A Medsger, James H Dauber, et al.
Journal of the American College of Radiology : JACR|May 26, 2023
ACR Appropriateness Criteria® Routine Chest Imaging, Tami J Bang, Jonathan H Chung, et al.
Lung Cancer (Amsterdam, Netherlands)|February 21, 2021
Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapyCole Friedes, Turja Chakrabarti, Sarah Olson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2012
Lung cancer screeningDouglas E Wood, George A Eapen, David S Ettinger, et al.
Cancers|November 9, 2024
Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and ImmunotherapyFyza Y Shaikh, Seoho Lee, James R White, et al.
The Annals of Thoracic Surgery|February 3, 2026
The Society of Thoracic Surgeons (2025) Expert Consensus Document on Interventions for Screen-Detected Lung NodulesElliot Servais, J W Awori Hayanga, Philip Linden, et al.
Nature Medicine|March 20, 2024
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analysesRonan J Kelly, Blair V Landon, Ali H Zaidi, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
The Annals of Thoracic Surgery|July 24, 2019
American Board of Thoracic Surgery 10-Year Maintenance of Certification Exam Improves and Validates Knowledge AcquisitionYolonda L Colson, Joe B Putnam, Stephen C Yang, et al.
Investigational New Drugs|February 28, 2006
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinomaElisabeth I Heath, Barbara A Burtness, Lawrence Kleinberg, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 2019
Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancerMatthew J Bott, Stephen C Yang, Bernard J Park, et al.
Arthritis and Rheumatism|November 30, 2006
Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertensionLionel Schachna, Thomas A Medsger, James H Dauber, et al.
Journal of the American College of Radiology : JACR|May 26, 2023
ACR Appropriateness Criteria® Routine Chest Imaging, Tami J Bang, Jonathan H Chung, et al.
Lung Cancer (Amsterdam, Netherlands)|February 21, 2021
Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapyCole Friedes, Turja Chakrabarti, Sarah Olson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2012
Lung cancer screeningDouglas E Wood, George A Eapen, David S Ettinger, et al.
Cancers|November 9, 2024
Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and ImmunotherapyFyza Y Shaikh, Seoho Lee, James R White, et al.
The Annals of Thoracic Surgery|February 3, 2026
The Society of Thoracic Surgeons (2025) Expert Consensus Document on Interventions for Screen-Detected Lung NodulesElliot Servais, J W Awori Hayanga, Philip Linden, et al.
Nature Medicine|March 20, 2024
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analysesRonan J Kelly, Blair V Landon, Ali H Zaidi, et al.
Pageof 17